Older adults experiencing irreversible blindness may now be able to see thanks to a system relying on a wireless retinal implant and high-tech glasses ...

Illumina (ILMN) reported $1.08 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 0.4%. EPS of $1.34 for the same period compares to $1.14 a year ago.

About Vaxxas Vaxxas is a biotechnology company pioneering a needle-free vaccination technology designed to enhance immune response, reduce costs, and improve accessibility. The company recently ...

DeciBio Consulting LLC, a leading market intelligence and strategy consulting firm, announced the publication of its first edition, "Proteomics Tools Report: Research and Clinical markets (2025-2030).

In participants with geographic atrophy due to age-related macular degeneration, a photovoltaic retina implant microarray (PRIMA) system leads to significant improvement in visual acuity.

Geographic atrophy, an advanced form of dry age-related macular degeneration, leaves almost five million people around the ...

A photovoltaic retinal implant shows promise as a way to improve vision in patients with advanced age-related macular ...